Innovative Respiratory Monitoring Respiratory Motion, Inc. specializes in non-invasive, continuous respiratory monitoring with its FDA-cleared ExSpiron device, offering real-time lung function data that can significantly improve patient outcomes across diverse healthcare settings.

Expanding Market Reach The company's recent product enhancements and global leadership position open opportunities to target hospitals, clinics, and outpatient care providers focused on advanced respiratory monitoring, particularly in settings emphasizing patient safety and cost reduction.

Strategic Acquisition Having been acquired by Senzime for $44M, Respiratory Motion demonstrates strong investor interest, which could facilitate expansion efforts and adoption in international markets or newer healthcare segments.

Growing Revenue Base With a revenue range of $1M to $10M and secured $18M in funding, the company presents a viable prospect for partnerships, distribution, or further sales engagement, especially within health systems prioritizing non-invasive respiratory solutions.

Leadership and Innovation Backed by an experienced leadership team, including recent appointments of prominent figures and a focus on device version upgrades, Respiratory Motion is positioned to penetrate respiratory care markets that value cutting-edge medical device technology.